Yongin-si, South Korea

Hee Cheol Kim


Average Co-Inventor Count = 6.6

ph-index = 1


Company Filing History:


Years Active: 2010-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Hee Cheol Kim

Introduction: Hee Cheol Kim is a renowned inventor based in Yongin-si, South Korea, known for his contributions in the field of pharmacology. With a total of three patents to his name, Kim has made significant strides in the modulation of G protein-coupled receptors, a key component in drug development.

Latest Patents: Among Kim's latest innovations is a bicyclic compound designed specifically for modulating G protein-coupled receptors. This invention is pivotal in providing treatment options for diseases associated with G protein-coupled receptors, particularly the GPR119 receptor. Another notable patent pertains to a method for the preparation of clopidogrel and its intermediates. This method allows for the high-yield optical resolution of racemic forms of clopidogrel, providing an optically pure form of the compound, showcasing Kim's expertise in medicinal chemistry.

Career Highlights: Hee Cheol Kim is an integral part of Hanmi Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work has been instrumental in developing new therapeutic strategies that leverage his innovative compounds and methods.

Collaborations: Throughout his career, Kim has collaborated with notable colleagues, including Eun Sook Kim and Bo Sung Kwon. This teamwork has fostered an environment of innovation, leading to advancements in drug development and therapeutic solutions.

Conclusion: Hee Cheol Kim's contributions as an inventor have had a substantial impact on the field of pharmacology and drug development. Through his patents and collaborative efforts at Hanmi Pharmaceutical Co., Ltd., he continues to advance the boundaries of medical science, offering new hope in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…